Cargando…
Effects of Antiviral Therapy and Glucocorticoid Therapy on Fever Duration in Pediatric Patients with Influenza
Background and Objectives: Considering developing resistance against neuraminidase inhibitors (NAIs) and their adverse reactions, restricted use of NAIs and use of alternative drugs should be considered for treating influenza. Although glucocorticoids (GCs) have been used for severe influenza, their...
Autores principales: | Han, Ji Yoon, Yang, Eun Ae, Rhim, Jung-Woo, Han, Seung Beom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707365/ https://www.ncbi.nlm.nih.gov/pubmed/34946330 http://dx.doi.org/10.3390/medicina57121385 |
Ejemplares similares
-
Clinical features and outcomes of influenza by virus type/subtype/lineage in pediatric patients
por: Han, Seung Beom, et al.
Publicado: (2021) -
High-Concentration Intravenous Immunoglobulin May Influence the Course of Fever and Rate of Reported Treatment Resistance in Children With Kawasaki Disease: A Single-Center Retrospective Analysis
por: Han, Seung Beom, et al.
Publicado: (2022) -
Seizures Related to Influenza in Pediatric Patients: A Comparison with Seizures Associated with Other Respiratory Viral Infections
por: Han, Ji Yoon, et al.
Publicado: (2021) -
Early Corticosteroid Therapy for Mycoplasma pneumoniae Pneumonia Irrespective of Used Antibiotics in Children
por: Yang, Eun-Ae, et al.
Publicado: (2019) -
Early Confirmation of Mycoplasma pneumoniae Infection by Two Short-Term Serologic IgM Examination
por: Jeon, Ha Eun, et al.
Publicado: (2021)